New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 19, 2014
08:50 EDTLMNX, LHLabCorp announces availability of xTAG CYP2D6 genotype assay
LabCorp (LH) announced the availability of the xTAG CYP2D6 Kit v3 from Luminex (LMNX). The xTAG CYP2D6 Kit v3 is an FDA cleared qualitative genotyping assay that aids clinicians in determining strategies for therapeutics metabolized by the CYP2D6 gene product.
News For LH;LMNX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 3, 2015
08:46 EDTLHLabCorp expands partnership with PTQ
Subscribe for More Information
August 26, 2015
08:33 EDTLMNXLuminex submits 510(k) application for the NxTAG respiratory pathogen panel
Luminex has submitted a 510(k) application to the FDA for the company's NxTAG Respiratory Pathogen Panel, a respiratory assay that will enable laboratories to simultaneously detect 21 respiratory pathogens in a single closed tube system in a format that scales to changes in throughput requirements and responds to seasonal changes in demand.
August 24, 2015
16:17 EDTLHLabCorp: Covance announces agreement with leading pharmaceutical company
Laboratory Corporation of America Holdings announced that Covance Drug Development has received a multi-year award from a leading pharmaceutical company to use Covance's Xcellerate platform as an exclusive central monitoring solution for their worldwide clinical trials portfolio. This landmark agreement with a top-tier pharmaceutical company for Covance's first-in-kind Software-as-a-Service offering reflects the company's unique technology capabilities, and reinforces its position as an industry innovator and leader in clinical informatics solutions.
08:45 EDTLHLabCorp announces availability of VistaSeq Hereditary Cancer Panel
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use